Project Details
| Status | Active |
|---|---|
| Effective start/end date | 27/02/24 → 26/02/29 |
Clinical Trial Phase
- Phase III (a & b)
SELECT-SLE: A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Moderately to Severely Active SLE
- Hoi, Alberta (Primary Chief Investigator (PCI))
Project: Research